Trial
NCT07375212
VAPorized Administration of Bumetanide for Outpatient Relief in Heart Failure
Phase IVWITHDRAWNOTHER/UNKNOWNConfidence: LOW
Sponsor
Prisma Health-Upstate
Collaborators
—
Condition
Heart Failure Congestive
Intervention
Bumetanide, intranasal 4mg
Why stopped
Change in Sponsor
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2026-01-29